Streptococcus pneumoniae: Difference between revisions

From IDWiki
Streptococcus pneumoniae
(Added Clinical Presentation)
(: added susceptibility info and resistance subsection)
Line 4: Line 4:
 
* 90+ serotypes, based on capsular polysaccharide that is bound to peptidoglycan
 
* 90+ serotypes, based on capsular polysaccharide that is bound to peptidoglycan
 
* Lab identification is based on [[Has hemolysis pattern::α-hemolysis]] of blood agar (from pneumolysin), [[Has susceptibility to::optochin]] susceptibility, and bile salt solubility
 
* Lab identification is based on [[Has hemolysis pattern::α-hemolysis]] of blood agar (from pneumolysin), [[Has susceptibility to::optochin]] susceptibility, and bile salt solubility
  +
* Via transformation, bacteria can exchange genetic material with each other
  +
  +
=== Susceptibility testing ===
  +
  +
* CLSI penicillin breakpoints for susceptibility changed in 2008
  +
** For meningitis: ≤0.06 μg/mL
  +
** For other infections: ≤2 μg/mL
  +
  +
=== Antibiotic resistance ===
  +
  +
* '''[[Penicillin]]''' resistance
  +
** ''S. pneumoniae'' has 6 PBPs: 1A, 1B, 2A, 2B, 2X, and 3
  +
** Resistance in any of the PBPs can increase the MIC
  +
** Mutations in PBP 2B are associated with low-level resistance
  +
** Mutations in PBP 2X are associated with high-level resistance
  +
* '''[[Macrolides|Macrolide]]''' resistance
  +
** ''ermB'' encodes an enzyme that methylates the 23S subunit, blocking macrolides
  +
** ''mefA'' encodes an efflux pump
   
 
== Epidemiology ==
 
== Epidemiology ==

Revision as of 22:11, 2 October 2019

Microbiology

  • Gram-positive, lancet-shaped diplococci
  • 90+ serotypes, based on capsular polysaccharide that is bound to peptidoglycan
  • Lab identification is based on α-hemolysis of blood agar (from pneumolysin), optochin susceptibility, and bile salt solubility
  • Via transformation, bacteria can exchange genetic material with each other

Susceptibility testing

  • CLSI penicillin breakpoints for susceptibility changed in 2008
    • For meningitis: ≤0.06 μg/mL
    • For other infections: ≤2 μg/mL

Antibiotic resistance

  • Penicillin resistance
    • S. pneumoniae has 6 PBPs: 1A, 1B, 2A, 2B, 2X, and 3
    • Resistance in any of the PBPs can increase the MIC
    • Mutations in PBP 2B are associated with low-level resistance
    • Mutations in PBP 2X are associated with high-level resistance
  • Macrolide resistance
    • ermB encodes an enzyme that methylates the 23S subunit, blocking macrolides
    • mefA encodes an efflux pump

Epidemiology

  • Present worldwide
  • Major cause of morbidity and mortality in children
    • Leading cause of under-5 mortality worldwide

Pathophysiology

  • Acquired by coughing and sneezing
  • Asymptomatic carriage or colonization in the nasopharynx
  • Invasion through epithelial cells into the bloodstream, using the PAF and pIg receptors
  • Capsule and various proteins help it to evade immune system

Clinical Presentation

Asymptomatic carriage

  • 4-10% in the general adult population, usually lasting several weeks
  • Highest in children, up to 30-60% depending on the situation, lasting up to 6 months

Otitis media

Sinusitis

Bacteremia

Pneumonia

  • Acute onset of cough (92%), fatigue (63%), shortness of breath (47%), and dyspnea (23%) with documented or subjective fever (92%), chills (77%), sweats, purulent sputum, and pleuritic chest pain (79%)

Meningitis

  • Most common cause of meningitis in adults
  • Acquired by hematogenous spread from nasopharynx, or direct invasion from sinuses
  • May be secondary to otitis media or sinusitis
  • CSF leaks and other defects predispose to infection
  • Diagnostic yield in CSF decrease significantly 4 hours after administration of antibiotics